TransMedics Group, Inc. (TMDX)
87.09
-6.93
(-7.37%)
USD |
NASDAQ |
Nov 20, 11:01
TransMedics Group Free Cash Flow : 44.70M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 44.70M |
| June 30, 2026 | 79.04M |
| March 31, 2026 | 151.36M |
| December 31, 2025 | 133.59M |
| September 30, 2025 | 120.65M |
| June 30, 2025 | 17.35M |
| March 31, 2025 | -63.23M |
| December 31, 2024 | -80.94M |
| September 30, 2024 | -120.51M |
| June 30, 2024 | -220.97M |
| March 31, 2024 | -230.11M |
| December 31, 2023 | -192.09M |
| September 30, 2023 | -165.37M |
| June 30, 2023 | -40.78M |
| March 31, 2023 | -46.95M |
| Date | Value |
|---|---|
| December 31, 2022 | -57.72M |
| September 30, 2022 | -60.75M |
| June 30, 2022 | -52.96M |
| March 31, 2022 | -45.39M |
| December 31, 2021 | -32.38M |
| September 30, 2021 | -29.70M |
| June 30, 2021 | -26.75M |
| March 31, 2021 | -29.62M |
| December 31, 2020 | -30.72M |
| September 30, 2020 | -30.82M |
| June 30, 2020 | -29.99M |
| March 31, 2020 | -33.64M |
| December 31, 2019 | -32.45M |
| September 30, 2019 | -64.84M |
| June 30, 2019 | -65.57M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp. | 3.331B |
| Insulet Corp. | 232.60M |
| Abbott Laboratories | 6.757B |
| Baxter International, Inc. | 1.134B |
| Becton, Dickinson & Co. | 2.693B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 36.00M |
| Cash from Investing (Quarterly) | -13.71M |
| Cash from Financing (Quarterly) | -1.915M |
| Free Cash Flow Per Share (Quarterly) | 0.676 |
| Free Cash Flow to Equity (Quarterly) | 28.42M |
| Free Cash Flow to Firm (Quarterly) | 32.75M |
| Free Cash Flow Yield | 1.48% |